Melatonin is a hormone that is involved in a variety of physiological and pathological responses such as circadian rhythms, retinal physiology, seasonal breeding, cardiovascular regulation, anti-oxidative activity and oncogenesis.
Except anti-oxidative activity, melatonin may mediate its effect in vivo through melatonin receptors. Presently, two human melatonin receptor subtypes exist and are now defined as either the MT 1 8) (formerly known as the Mel 1a receptor) 9) and the MT 2 8) (formerly known as the Mel 1b receptor).
10) The ability of melatonin or melatonin-like compounds to bind to and elicit physiological responses is dependent upon specific interactions between the ligand and receptor. The elucidation of the components of melatonergic ligands that are involved in high-affinity binding is becoming clearer. Currently, what we know is that the indole ring of melatonin is not crucial for melatonin receptor recognition. For instance, the naphthalene ring [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] can serve as a bioisostere of the indole nucleus of melatonin and analog 2 was reported to have equivalent affinity to melatonin for melatonin receptors in ovine pars tuberalis. 11) In addition, other groups such as amidotetralin, 21) methoxychroman, 22) amido indane, 23) benzofuran, 18, 24) benzothiophene 18, 24) and quinoline 25) can serve as a bioisostere of the indole nucleus of melatonin. Langlois et al. reported that the addition of a 2-methoxy group (OMe) to compound 2 to form 3 results in an order of magnitude increase in receptor affinity over compound 2 (Fig. 1). 12) It was postulated that the 2-OMe group binds to the accessory binding site of the receptor. Recently, we reported the synthesis and receptor binding studies of several analogs of 3 (general structure 4) with the substituents either hydrophilic or hydrophobic in nature with different sizes. 16) Preliminary results show that analogs with smaller substituents in R, irrespective of their hydrophilic or hydrophobic nature, exhibit higher affinity for melatonin receptors when compared to those with larger substituents. We postulate that the close proximity of the amidoethyl side chain may be interfering with the conformation of the substituent on 2-position in 4 ( Fig. 1) . Thus, to determine the validity of this hypothesis, the amidoethyl group was transferred from C1 to C8 to eliminate the steric interference between the amidoethyl group and the substituent on 2-position in compound 4. The transfer should not affect the affinity of the ligands for the melatonin receptor as shown by Langlois et al. in which compound 5 (K i ϭ0.67 nM) has the same affinity for melatonin receptors in chicken brain when compared to compound 2 (K i ϭ0.54 nM) (Fig. 1) . 12) After eliminating the steric interference of the amidoethyl side chain and the substituents on 2-position, we then synthesized compounds 6-10 with the substituents on 7-position of varying sizes.
Results and Conclusions
Chemistry The synthesis of compounds 6-10 is summarized in Fig. 2 . Monobenzylation of 2,7-dihydroxynaphthalene 11 by reaction with 1 eq of benzyl bromide to form 12 (39%) followed by selective formylation at the 1-position (Reimer-Tiemann reaction) 26) yielded the desired phenolic aldehyde 13 (14%). The structure of 13 was confirmed unambiguously by 1 H-NMR spectra in which four protons have a large coupling constant of 9.0 Hz and the proton of OH moved downfield to 13.15 ppm. Methylation of 13 with methyl iodide formed 14 which was condensed with nitromethane in the presence of NH 4 OAc to furnish nitroalkene 15 (95% yield in 2 steps). Reduction of 15 with LiAlH 4 followed by acylation with propionyl chloride afforded amide 10 (63% yield based on 15). The benzyl group in 10 was removed in Pd-H 2 to give phenol 6 (100%). Treatment of 6 with various alkyl iodides yielded the corresponding alkylated products 7-9 (76-94% yield).
Melatonin Receptors Ligands' Binding Affinity The affinities of compounds 6-10 for melatonin receptors were evaluated in vitro and in duplicate by competition binding analysis using the radioligand 2-[ 125 I]-iodomelatonin (80-100 pM; DuPont, Boston, MA, U.S.A.) as described previously.
27) The competition binding assays were performed 3-5 times for each compound. The affinity of 2-[
125 I]-iodomelatonin for the MT 1 and MT 2 melatonin receptors was 80 and 150 pM, respectively. To ensure that the affinities of compounds 6-10 for the melatonin receptors were not artifact, these compounds, like melatonin, were dissolved in ethanol, the pipette tips were changed in between serial dilutions, and melatonin competition curves were run in parallel with every compound tested. As shown in Table 1 , compounds 6-10 displayed higher affinity than melatonin and exhibited subpicomolar binding affinities to both MT 1 and MT 2 receptors. The affinity of these compounds for the melatonin receptors increased from 0.85 pM to Ͻ0.01 pM as the RЈ substituent increased from H to n-Bu. A further increase in size of the RЈ substituent (benzyl) resulted in a decrease in binding affinity. However, this is in complete contrast to the affinities of compound 4 for MT 1 and MT 2 melatonin receptors in regard to varying the size of the RЈ substituent. In compound 4, the compound with the highest affinity to both MT 1 and MT 2 receptors are RЈϭCH 3 and C 2 H 5 . Any increase in size in the RЈ substituent results in a decrease in binding affinity. 16) It has been stated that the 5-methoxy group in melatonin is involved in critical hydrogen bonding to the receptor recognition site. 28) If it is assumed that the methoxy group in compound 4 mimics the 5-methoxy group of melatonin, then transferring the amidoethyl group from C1 to C8 eliminated the steric interference between the amidoethyl group and the 2 substituent in compound 4 and resulted in an increase in binding affinity to both MT 1 and MT 2 receptors.
In conclusion, A series of N-[2-(7-alkoxy-2-methoxy-1-naphthyl)ethyl]propionamides were prepared and their binding affinities on both MT 1 and MT 2 melatonin receptors were evaluated. The analogs exhibit high binding affinities to the receptors and the affinity of these compounds for the melatonin receptors decreased from 0.85 pM to Ͻ0.01 pM as the RЈ substituent increased from H to n-Bu. A further increase in size of the RЈ substituent (benzyl) resulted in a decrease in binding affinity.
Experimental
The Preparation of 7-(Benzyloxy)-2-naphthol (12) To a solution of 20.8 g (130 mmol) of 2,7-dihydroxynaphthalene 11 was added 15.2 g (110 mmol) of benzyl bromide. The reaction mixture was refluxed for 4 h and cooled to room temperature (r.t.). The reaction mixture was filtered and the filtrate was concentrated in vacuo. The residue was purified by column chromatography on silica gel using CH 2 Cl 2 -petroleum ether (4 : 1) as eluent, giving 10.8 g (39%) of monobenzylated product 12; mp 151. The Preparation of 7-(Benzyloxy)-2-hydroxy-1-naphthylaldehyde (13) 7-Benzyloxy-2-naphthol 12 (5.0 g, 20 mmol) was added to a solution of NaOH (6.4 g, 0.16 mol) in 40 ml of water and the mixture was heated to 65-70°C. Chloroform (3.6 ml, 44.8 mmol) was added to the mixture in three portions at intervals of 15 min. After the addition of CHCl 3 , the reaction mixture was stirred at 100°C for 1 h. After cooling, the reaction mixture was acidified with diluted sulfuric acid and then extracted with CH 2 Cl 2 (3ϫ60 ml). The organic extracts were dried (Na 2 SO 4 ) and evaporated. The residue was purified by silica gel chromatography using CH 2 
The Preparation of 7-(Benzyloxy)-2-methoxy-1-[(E)-2-nitroethenyl]-naphthalene (15)
A solution of the aldehyde 14 (1.72 g, 5.9 mmol) and ammonium acetate (0.3 g, 3.9 mmol) in nitromethane (18.4 ml) was refluxed for 4 h. After evaporation of the solvent in vacuo, the residue was dissolved in CH 2 Cl 2 (30 ml) and H 2 O (25 ml) was added. The organic layer was separated and the aqueous layer was extracted with CH 2 Cl 2 (2ϫ25 ml). The combined organic extracts were washed with H 2 O (30 ml) and then dried (Na 2 SO 4 ). Evaporation of the solvent under reduced pressure gave 1.97 g (ϳ100%) of pure product 15; mp 163-164.5°C; in anhydrous tetrahydrofuran (THF) (60 ml) at 0°C was added dropwise a solution of compound 15 (1.5 g, 4.48 mmol) in THF (20 ml). The reaction mixture was stirred at 40°C for 18 h and then cooled to 0°C. Solutions were then added to the mixture in the following order: H 2 O (1.0 ml), 15% NaOH solution (1.0 ml), EtOAc (50 ml) and H 2 O (30 ml). The mixture was filtered, and the filtrate was dried (Na 2 SO 4 ). The solvent was evaporated in vacuo and the crude product thus obtained was dried overnight in vacuo and used for the next step without further purification.
To a solution of the above crude product in anhydrous CH 2 Cl 2 (25 ml) at 0°C were added triethylamine (1.2 ml, 8.6 mmol) in one portion and then propionyl chloride (0.5 ml, 5.72 mmol) dropwise. The reaction mixture was stirred at r.t. for 1 h and was diluted with CH 2 Cl 2 (30 ml), washed with saturated NaHCO 3 solution (20 ml) and H 2 O (20 ml). The organic layer was dried (Na 2 SO 4 ) and concentrated. The residue was purified by silica gel chromatography using petroleum ether : EtOAc (1 : 1) as eluent, yielding 880 mg (54% based on compound 15) of amide 10; mp 121. The Preparation of N-[2-(7-Hydroxy-2-methoxy-1-naphthyl)ethyl]propionamide (6) Amide 10 (1.2 g, 3.3 mmol) in methanol (38 ml) was hydrogenated over 10% Pd on activated carbon at r.t. for 18 h. The reaction mixture was filtered through celite. The filtrate was concentrated and purified by silica gel chromatography using petroleum ether-EtOAc (1 : 2) as eluent, yielding 0.9 g (ϳ100%) of compound 6; mp 118-120°C; 1 
